Patients with allergic or autoimmune diseases are at higher risk for functional gastrointestinal disorders independent of psychological distress, according to research published in Alimentary Pharmacology & Therapeutics.
Nicholas J. Talley, MD, PhD, of the faculty of health & medicine at the University of Newcastle in Australia, and colleagues wrote that immune activation appears to be a significant factor in the development of FGIDs.
“Evidence for innate immune activation in the mucosa in [irritable bowel syndrome] and [functional dyspepsia] has been observed, but the prevalence

Source link